Contact Us
Drug Search Results
More Filters [+]

Spebrutinib

Alternative Names: spebrutinib, avl-292, cc-292
Latest Update: 2024-02-22
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Btk Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Bristol-Myers Squibb
Company Location: NEW YORK NY 10016
Company CEO: Giovanni Caforio
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Spebrutinib

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Arthritis, Rheumatoid

Phase 1: Lymphoma, B-Cell|Follicular Lymphoma|Diffuse Large B-Cell Lymphoma|Lymphocytic Chronic B-Cell Leukemia|Healthy Volunteers|Chronic Lymphoid Leukemia|Waldenstrom Macroglobulinemia|Lymphoma, Non-Hodgkin

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CC-122-DLBCL-001

P1

Terminated

Follicular Lymphoma|Diffuse Large B-Cell Lymphoma

2023-12-12

CC-292-CLL-001

P1

Completed

Chronic Lymphoid Leukemia|Lymphocytic Chronic B-Cell Leukemia

2019-01-23

47%
CC-292-RA-001

P2

Completed

Arthritis, Rheumatoid

2016-01-01

CC-292-CLL-002

P1

Completed

Lymphoma, B-Cell|Chronic Lymphoid Leukemia|Lymphocytic Chronic B-Cell Leukemia

2015-12-01

Recent News Events

Date

Type

Title

02/22/2024

PubMed

 Discovery of Novel Potent and Fast BTK PROTACs for the Treatment of Osteoclasts-Related Inflammatory Diseases.

08/23/2023

PubMed

 Influence of Bruton's Tyrosine Kinase (BTK) on Epithelial-Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC).

06/09/2023

PubMed

 Reactive intermediates formation and bioactivation pathways of spebrutinib revealed by LC-MS/MS: In vitro and in silico metabolic study.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions